Consolidators brace for decision on California’s controversial SB 977; Kohlberg makes big splash for Partners’ PCI Pharma
Blackstone Tactical Opportunities will be investing $275 million in Cryoport to support two new acquisitions in the cell and gene therapy supply chain.
